Palatin Technologies
PTN
#10125
Rank
A$46.22 M
Marketcap
A$26.08
Share price
0.66%
Change (1 day)
8,576.10%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$37.74 Million, an increase over its 2023 earnings that were of -A$45.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-78.98%
2024 -A$37.74 Million-16.9%
2023 -A$45.41 Million5.99%
2022 -A$42.85 Million-13.7%
2021 -A$49.65 Million33.25%
2020 -A$37.26 Million-172.11%
2019 A$51.66 M2352.33%
2018 A$2.1 M-94.13%
2017 A$35.89 M-154.92%
2016 -A$65.37 Million3.67%
2015 -A$63.05 Million878%
2014 -A$6.45 Million-72.64%
2013 -A$23.57 Million-33.11%
2012 -A$35.23 Million77.71%
2011 -A$19.83 Million
2003 -A$33.57 Million29.93%
2002 -A$25.84 Million36.18%
2001 -A$18.97 Million
1999 -A$15.75 Million6.04%
1998 -A$14.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.99 B-699,817.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.76 B-294,318.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$0.89 B-13,374.02%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.82 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.22 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$70.8 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$41.31 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$77.82 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA